Latest news
News
-
14 January 2019
Xeljanz (Tofacitinib) - New Psoriatic Arthritis Treatment Approved for Use in Scotland
The SMC approves Xeljanz (Tofacitinib) for the treatment of psoriatic arthritis in adults in Scotland.
-
19 December 2018
Zudaifu - ‘Herbal’ Cream Found to Contain an Undeclared Steroid and Antifungal Ingredients
The MHRA urges anyone who has purchased Zudaifu cream to discontinue use immediately.
-
18 December 2018
Emollient Build Up in Clothing and Bedding Can Pose a Fire Hazard
Care should be taken to keep clothing and bedding that may contain emollient residue away from naked flames.
-
2 November 2018
Top Ten Psoriasis Research Priorities Announced
The 'Top Ten' list, agreed upon by patients, carers and clinicians marks the culmination of the psoriasis Priority Setting Partnership (PSP).
-
16 October 2018
Humira (Adalimumab) - Most Commonly Prescribed Biologic for Psoriasis Comes Off Patent
AbbVie's Humira (Adalimumab) comes off patent, paving the way for 'biosimilar' products to be offered on the NHS.